Abstract
Background The use of single-dose primaquine to block transmission of Plasmodium falciparum malaria is complicated by variation in glucose-6-phosphate-dehydrogenase (G6PD) activity and potentially cytochrome P450 2D6 (CYP2D6). G6PD deficiency determines primaquine safety while the CYP2D6 metabolizer phenotype may determine primaquine efficacy by influencing metabolism into active metabolite(s). While there is evidence that the CYP2D6 metabolizer phenotype influences primaquine efficacy against P. vivax hypnozoites, there is currently no evidence for CYP2D6 in relation to its gametocytocidal activity in P. falciparum.
Highlights
cytochrome P450 2D6 (CYP2D6) intermediate metabolizer status could slow down Plasmodium falciparum gametocyte clearance after single-dose primaquine
The use of single-dose primaquine to block transmission of Plasmodium falciparum malaria is complicated by variation in glucose-6-phosphate-dehydrogenase (G6PD) activity and potentially cytochrome P450 2D6 (CYP2D6)
The number of poor metabolizers (PM) is low in our study population and does not allow a firm conclusion on its impact on gametocyte clearance following primaquine
Summary
The use of single-dose primaquine to block transmission of Plasmodium falciparum malaria is complicated by variation in glucose-6-phosphate-dehydrogenase (G6PD) activity and potentially cytochrome P450 2D6 (CYP2D6). G6PD deficiency determines primaquine safety while the CYP2D6 metabolizer phenotype may determine primaquine efficacy by influencing metabolism into active metabolite(s). While there is evidence that the CYP2D6 metabolizer phenotype influences primaquine efficacy against P. vivax hypnozoites, there is currently no evidence for CYP2D6 in relation to its gametocytocidal activity in P. falciparum
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.